Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Comment by CCAbbott888on Apr 29, 2019 7:46pm
163 Views
Post# 29686190

RE:RE:RE:Anyone think the market has repriced PLI's value

RE:RE:RE:Anyone think the market has repriced PLI's value
GoBBs wrote: thats not what I'm asking ...what I'm wondering is has the market respriced this up already. Theres 20B shares now ...and its not trading at .0147  294m/20b ......its trading 4x that so wondering why.

GoBBs, I think that buys now at 6-7 cents are 1. are day traders (see examples here on stocktwits pli forum posts) 2. retailers who don't have a prior position, and are buying now for the rights-offer. 

Here is the math, if interested.

their cost average after the rights

in the case of x6.7, $0.022=($0.07+$0.01521x6.7)/(1+6.7) shares

or in the case of x20, $0.018=($0.07+$0.01521x20)/(1+20) shares

Without any prior position, their average cost after the rights is low, which for some people are worth the risk for the potential upside.

It will only become clear, imo, what the market values PLI at AFTER the annoucement of the Record date in May.

My guess is that it will go lower than the current 6-7 cents, but how close to the transaction price of 1.521 cents, nobody knows.

If sp stays higher than 1.521 cents after the annoucement of the record day, then it is clear that the rights offer is the more advantageous way (i.e. a better price) to average down, for those who decide to do so than buy at the market.
Bullboard Posts